Published in PLoS One on March 25, 2015
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The hallmarks of cancer. Cell (2000) 113.05
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol (1999) 3.15
The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (1989) 2.52
Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol (2006) 2.40
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol (2011) 1.74
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res (2005) 1.71
Poorly differentiated and anaplastic thyroid cancer. Cancer Control (2006) 1.66
Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab (2005) 1.63
Anaplastic thyroid cancer. Curr Opin Oncol (2003) 1.54
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab (2004) 1.36
Genome-wide appraisal of thyroid cancer progression. Am J Pathol (2002) 1.28
Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg (2014) 1.26
Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid. Mol Endocrinol (2002) 1.17
Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.13
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions. Mol Cell Endocrinol (2010) 1.13
Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol (2008) 1.04
AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod Pathol (2011) 1.02
Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer. PLoS One (2013) 1.01
Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid (2006) 0.99
Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer (2004) 0.98
Aurora kinases as prognostic biomarkers in ovarian carcinoma. Hum Pathol (2009) 0.97
Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines. Endocr Relat Cancer (2008) 0.97
Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer. Lung Cancer (2013) 0.97
Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer (2006) 0.96
Aurora-A as an independent molecular prognostic marker in gastric cancer. Oncol Rep (2011) 0.93
Prognostic significance of Aurora-A expression in human bladder cancer. Acta Histochem (2010) 0.91
Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr Relat Cancer (2007) 0.90
High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. Strahlenther Onkol (2012) 0.90
Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. Br J Cancer (2012) 0.89
Well differentiated thyroid cancer. Curr Opin Oncol (2003) 0.89
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol (2010) 0.89
Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome. Thyroid (2013) 0.88
The urokinase plasminogen activating system in thyroid cancer: clinical implications. G Chir (2012) 0.86
Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines. Endocr Relat Cancer (2014) 0.85
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. Clin Endocrinol (Oxf) (2012) 0.85
Identification of aurora kinase B and Wee1-like protein kinase as downstream targets of (V600E)B-RAF in melanoma. Am J Pathol (2013) 0.85
BubR1 and AURKB overexpression are associated with a favorable prognosis in gastric cancer. Mol Med Rep (2011) 0.85
Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database. Thyroid (2015) 0.84
High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma. J Clin Endocrinol Metab (2010) 0.84
Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab (2001) 0.81
Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis. Pediatr Blood Cancer (2013) 0.80
A new aurora in anaplastic thyroid cancer therapy. Int J Endocrinol (2014) 0.79
Effects of the Aurora kinases pan-inhibitor SNS-314 mesylate on anaplastic thyroid cancer derived cell lines. Clin Ter (2012) 0.79
Aurora kinases: new molecular targets in thyroid cancer therapy. Clin Ter (2012) 0.78
Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution. Oncol Lett (2012) 0.77
The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity. J Biol Regul Homeost Agents (2013) 0.76
Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? BMC Clin Pathol (2013) 0.83
Do Not Forget Nephrotic Syndrome as a Cause of Increased Requirement of Levothyroxine Replacement Therapy. Eur Thyroid J (2015) 0.82
Thyroid nodules and thyroid autoimmunity in the context of environmental pollution. Rev Endocr Metab Disord (2015) 0.81
Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series. Endocrine (2016) 0.81
Strain ratio ultrasound elastography increases the accuracy of colour-Doppler ultrasound in the evaluation of Thy-3 nodules. A bi-centre university experience. Eur Radiol (2015) 0.80
Association between Pituitary Langerhans Cell Histiocytosis and Papillary Thyroid Carcinoma. Clin Med Insights Case Rep (2013) 0.80
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis. Cancer Cytopathol (2016) 0.79
Parathyroidectomy for primary hyperparathyroidism in the elderly: experience of a single endocrine surgery center. Aging Clin Exp Res (2016) 0.78
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia. Hormones (Athens) (2014) 0.77
Personalization of targeted therapy in advanced thyroid cancer. Curr Genomics (2014) 0.77
Systemic Lupus Erythematosus and Thyroid Autoimmunity. Front Endocrinol (Lausanne) (2017) 0.76
Role of CXCL10 in cryoglobulinemia. Clin Exp Rheumatol (2015) 0.76
Postpartum Mood Disorders and Thyroid Autoimmunity. Front Endocrinol (Lausanne) (2017) 0.75
Selective use of vandetanib in the treatment of thyroid cancer. Drug Des Devel Ther (2015) 0.75
Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line. Endocrine (2015) 0.75
Serum Thyrotropin and Phase of the Menstrual Cycle. Front Endocrinol (Lausanne) (2017) 0.75
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia. Front Endocrinol (Lausanne) (2017) 0.75
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer. Int J Oncol (2017) 0.75
Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity. Front Endocrinol (Lausanne) (2017) 0.75
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis (2017) 0.75
Inferior thyroid artery ligation increases hypocalcemia after thyroidectomy: A meta-analysis. Laryngoscope (2017) 0.75
Associations between Systemic Sclerosis and Thyroid Diseases. Front Endocrinol (Lausanne) (2017) 0.75